Patient characteristics | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Infiltrate | No. | Gender | Age | Â | Â | Â | Â | A | C | R | Â | Â | Â | Â | Prednisone | Hydroxychloroquine | Azathio prine | Autoantibody | MED |
 |  |  | (years) | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | (mg/day) | (mg/day) | (mg/day) | specificities | (J/cm2) |
+ | 1 | F | 34 | + | - | - | - | + | - | - | - | + | + | + | 3.75 | 400 | - | SSA/nRNP/dsDNA/Sm/phosL | 0.090 |
- | 2 | F | 64 | - | + | - | - | - | - | - | - | + | + | + | 10 | - | 100 | dsDNA/SSA/phosL | 0.280 |
- | 3 | F | 33 | + | - | - | - | + | + | + | - | + | + | + | 5 | 400 | 100 | dsDNA | 0.075 |
- | 4 | F | 53 | + | - | + | - | + | + | + | - | + | + | + | 5 | - | 75 | dsDNA | 0.070 |
- | 5 | F | 36 | - | - | - | - | + | + | - | - | + | + | + | - | 600 | - | dsDNA/nRNP | 0.100 |
+ | 6 | M | 76 | - | - | - | - | + | + | + | + | + | + | + | 7.5 | - | - | dsDNA/SSA | 0.090 |
- | 7 | M | 38 | + | - | - | - | - | - | - | - | - | - | - | 5 | - | 75 | dsDNA/SSA/SSB | 0.050 |
+ | 8 | F | 64 | - | - | - | - | + | + | - | - | + | + | + | - | - | 150 | dsDNA | 0.180 |
- | 9 | F | 50 | - | - | - | - | + | - | + | - | + | + | + | 10 | - | 100 | dsDNA/SSA | 0.180 |
- | 10 | M | 67 | - | - | + | - | - | - | + | - | + | - | + | 3.5 | - | 25 | SSA/phosL | 0.070 |
- | 11 | F | 42 | - | - | + | + | + | - | - | - | - | + | + | 5 | 400 | 75 | dsDNA/SSA/nRNP/Sm | 0.130 |
+ | 12 | M | 49 | - | - | + | - | + | + | - | - | - | - | + | 5 | - | - | nRNP | 0.100 |
- | 13 | F | 57 | - | + | - | - | + | - | + | - | + | + | + | 5 | - | 100 | dsDNA/Sm | 0.085 |
+ | 14 | F | 53 | - | - | + | - | + | - | - | - | - | + | + | - | 200 | - | dsDNA/nRNP | 0.075 |
- | 15 | F | 47 | + | + | + | - | - | - | + | - | + | - | + | 5 | - | 150 | SSA/phosL | 0.075 |